Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -2.27% vs -74.27% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 1,675.00% vs 0.00% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 240.37% vs 442.20% in Mar 2025
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
3.18
20.53
645.60%
Share Warrants & Outstandings
Total Reserve
5.91
37.70
-31.79
-84.32%
Shareholder's Funds
29.61
40.88
-11.27
-27.57%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.33
-0.33
-100.00%
Secured Loans
0.00
0.33
-0.33
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.01
0.07
-0.06
-85.71%
Other Long Term Liabilities
0.11
0.00
0.11
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.12
0.41
-0.29
-70.73%
Current Liabilities
Trade Payables
54.88
2.80
52.08
1,860.00%
Other Current Liabilities
1.28
2.31
-1.03
-44.59%
Short Term Borrowings
0.43
1.48
-1.05
-70.95%
Short Term Provisions
0.00
0.01
-0.01
-100.00%
Total Current Liabilities
56.58
6.60
49.98
757.27%
Total Liabilities
86.32
47.88
38.44
80.28%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.75
4.03
-3.28
-81.39%
Less: Accumulated Depreciation
0.04
1.68
-1.64
-97.62%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.71
2.35
-1.64
-69.79%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
1.51
0.13
1.38
1,061.54%
Other Non Current Assets
0.00
0.06
-0.06
-100.00%
Total Non-Current Assets
2.35
2.54
-0.19
-7.48%
Current Assets Loans & Advances
Current Investments
0.00
2.51
-2.51
-100.00%
Inventories
0.00
1.52
-1.52
-100.00%
Sundry Debtors
70.78
7.46
63.32
848.79%
Cash and Bank
10.58
2.53
8.05
318.18%
Other Current Assets
0.00
0.35
-0.35
-100.00%
Short Term Loans and Advances
2.61
30.96
-28.35
-91.57%
Total Current Assets
83.97
45.34
38.63
85.20%
Net Current Assets (Including Current Investments)
27.38
38.74
-11.36
-29.32%
Total Current Assets Excluding Current Investments
83.97
42.82
41.15
96.10%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.32
47.88
38.44
80.28%
Contingent Liabilities
0.48
1.45
-0.97
-66.90%
Total Debt
0.43
1.81
-1.38
-76.24%
Book Value per share (adjusted)
12.49
128.61
-116.12
-90.29%
Annual - Borrowings
Borrowings 0.43 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.27% vs -74.27% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.11 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.71 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1,675.00% vs 0.00% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 83.97 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 240.37% vs 442.20% in Mar 2025
